Clinical Trial Update: Recombinant Adenoviral Human p53 Gene in Treatment of Malignant Pleural Effusion [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating recombinant adenoviral human p53 gene therapy for malignant pleural effusion; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malignant Pleural Effusion

Drugs mentioned

• Recombinant Adenoviral Human p53 Gene (p53 gene therapy)

Snippet

Sponsor: Shenzhen SiBiono GeneTech Co.,Ltd | Conditions: Malignant Pleural Effusion | Phase 2 | Status: UNKNOWN